22 April 2005 Final Programme - The British Society for Rheumatology
22 April 2005 Final Programme - The British Society for Rheumatology
22 April 2005 Final Programme - The British Society for Rheumatology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Lupus Hall 9<br />
Co-convenors: Ian Bruce and Bridget Griffiths<br />
Aims and objectives: <strong>The</strong> purpose of the group is to in<strong>for</strong>m and update BSR<br />
members who have an interest in Lupus about current research taking place.<br />
In particular there are multi centre collaborative studies that are taking place which<br />
they could take part in.<br />
• Current multicentre studies in SLE. Ian Bruce, Bridget Griffiths<br />
• <strong>The</strong> new BILAG 2004 index; current update. Chee-Seng Yee<br />
• Subclinical atherosclerosis in a SLE cohort. Yasmeen Ahmad<br />
• Future therapies <strong>for</strong> SLE. Bevra Hahn<br />
PMR/Giant cell arteritis Hall 7B<br />
Convenor: Bhaskar Dasgupta<br />
Aims and Objectives: Attendees to this session will learn about the exciting<br />
scientific programme of the Third International Conference on GCA and PMR to be<br />
held at St John’s College, Cambridge on 24 th – 27 th July, <strong>2005</strong>. <strong>The</strong> BSR also wishes to<br />
develop guidelines <strong>for</strong> the management of PMR and GCA. We will discuss the<br />
<strong>for</strong>mation of a multi-disciplinary guidelines group <strong>for</strong> PMR and GCA. A very<br />
preliminary review of the literature on PMR will be presented along with draft<br />
guidelines <strong>for</strong> discussion.<br />
• Third international conference on GCA/PMR, St John’s College,<br />
24 – 27 July <strong>2005</strong>. Brian Hazleman<br />
• Scientific programme <strong>for</strong> GCA/PMR meeting. Paul Bacon<br />
• BSR committee on quality, guidelines and audit standards. Tom Kennedy<br />
• A preliminary review of literature on PMR. Nada Hassan<br />
• Draft guidelines <strong>for</strong> management of GCA and PMR. Way Main Wong<br />
RA Outcomes Hall 8B<br />
Convenor: Adam Young<br />
• <strong>The</strong> national database <strong>for</strong> German arthritis centres. Angela Zink<br />
• Databases and audit tools <strong>for</strong> RA. BSR Working Party<br />
• Health care commission perspective. Jonathan Boyce<br />
• Cachexia and functional disability in RA. Kathryn Chester, Sam Marcora and<br />
Peter Maddison<br />
Soft tissue and sports medicine Hall 6A<br />
Convenor: Cathy Speed<br />
• Sports & exercise medicine in rheumatology. Roger Wolman<br />
• Tendinopathies: scientific update. Graham Riley<br />
• Tendinopathies: therapies old and new. Cathy Speed<br />
Spondyloarthritis: Recent advances in genetics and treatment of ankylosing<br />
spondylitis Hall 8A<br />
Convenor: Paul Bowness<br />
Target Audience: practicing clinicians with an interest in spondyloarthritis and/or<br />
anti-TNF therapy, and individuals with scientific interest in the pathogenesis and<br />
genetics of spondyloarthritis. All welcome.<br />
Aims & Objectives: to increase the audience’s knowledge of the genetic basis of,<br />
and current research in SpA, and to give participants an up to date knowledge of the<br />
indications <strong>for</strong>, assessment of, and pitfalls involved in treatment of Spa with TNF<br />
blockers.<br />
• Recent advances in genetics of AS. Paul Wordsworth<br />
• Anti-TNF treatment <strong>for</strong> AS, update from clinical trials and practical considerations.<br />
Paul Emery<br />
• Open discussion<br />
14
Change language